Amanote Research

Amanote Research

    RegisterSign In

Sunitinib Effective for Rare Thymus Cancer

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2015-017
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

February 13, 2015

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)


Related search

Sunitinib for Advanced Renal Cell Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma

Case Reports in Oncological Medicine
Oncology
2018English

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

Journal of Cancer
Oncology
2017English

Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer

Annals of Surgical Oncology
OncologySurgery
2015English

Tumor Endothelial ELTD1 as a Predictive Marker for Treatment of Renal Cancer Patients With Sunitinib

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Nanoparticles for Effective Combination Therapy of Cancer

International Journal of Nanotechnology and Nanomedicine
2016English

Antitumor Effect of Sunitinib in Human Prostate Cancer Cells Functions via Autophagy

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

SBRT Effective for Inoperable Early-Stage Lung Cancer

Cancer Discovery
Oncology
2014English

Surgery for Recurrent Pancreatic Cancer: Is It Effective?

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy